IRVINE, Calif. Ista Pharmaceuticals has won approval from the Food and Drug Administration for a drug used to treat eye surgery patients.
The drug maker announced the approval of Bromday (bromfenac) ophthalmic solution as a once-daily eye drop for treating pain and inflammation in patients who have received cataract extraction surgery. The drug is a nonsteroidal anti-inflammatory drug, or NSAID, belonging to the same class as the common painkiller ibuprofen. The company plans to launch the drug at the end of this year.
